Photoalteration of calcium channel blockade in the cardiac Purkinje fiber  by Sanguinetti, M.C. & Kass, R.S.
PHOTOALTERATION OF CALCIUM CHANNEL BLOCKADE
IN THE CARDIAC PURKINJE FIBER
M. C. SANGUINETrl AND R. S. KAss
University ofRochester, School ofMedicine and Dentistry, Rochester, New York 14642
ABSTRACT Organic compounds that block calcium channel current (calcium antagonists) are important tools for the
characterization of this channel. However, the practically irreversible nature of this block restricts the usefulness of this
group of drugs. In this paper, we investigate the influence of light on calcium channel blockade by several organic
compounds. Our results show that inhibition of calcium channel current by two dihydropyridine derivatives that contain
an o-nitro moiety (nisoldipine and nifedipine) can be rapidly reversed by illumination. The energy range important to
this reaction is for light wavelengths between 320 and 450 nm. Calcium channel inhibition by two other dihydropyridine
derivatives (nicardipine and nitrendipine) as well as by D600, is not modulated by illumination. These results indicate
that the photosensitivity of certain dihydropyridine calcium channel blockers makes these compounds useful as
reversible blockers of this channel.
INTRODUCTION
Calcium channels exist in a wide variety of cells and
participate in many aspects of cellular function (Hagiwara
and Byerly, 1981; Fenwick et al., 1982; Tsien, 1983;
Reuter, 1983). In many of these cells ion flow through
these channels can be inhibited by several organic and
inorganic compounds (Henry, 1980; Lee and Tsien, 1983).
These compounds are referred to as "Ca antagonists"
(Fleckenstein, 1977) or "Ca channel blockers" (Triggle,
1982). Quantitative investigation of the properties of cal-
cium channels in any cell type often requires selective and
complete block of ion movement through these channels.
Complete block of calcium channel current reveals a
background current that is not necessarily a linear function
of membrane potential (Brown et al., 1981). Subtraction of
the background current can be accomplished by forming
the difference between traces measured in the absence and
presence of a maximal concentration of blocker. This
procedure has already been used to investigate the calcium
channel reversal potential in Helix aspersa (Brown et al.,
1981) and cardiac ventricular cells (Lee and Tsien, 1982),
as well as to describe a component of calcium channel
current that fails to completely inactivate during prolonged
depolarizations in the cardiac Purkinje fiber (Kass et al.,
1976).
The advantage of using the organic inhibitors in these
experiments is that some of these compounds tend to be
more selective for the calcium channel than the inorganic
blockers (Kass and Tsien, 1975). The disadvantage of
organic blockers is that they are practically irreversible or
are so only after prolonged periods of washout presumably
due to their extremely lipophilic nature. Experiments
designed to investigate the modes of action of these com-
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pounds on the calcium channel frequently require observa-
tion of changes in calcium channel current brought on by
low concentrations of these inhibitors.
Measurement of changes in current due to low concen-
trations of drug are also essential for determining the
relative blocking potency of these compounds. This in turn
will provide crucial information for comparison with bind-
ing studies (Bolger et al., 1982; Ehlert et al., 1982) in
attempts to count and purify calcium channels. Without a
reversible inhibitor, it is impossible to distinguish between
drug-induced reduction in this current and that due to
run-down of the preparation (for example see Fenwick et
al., 1982).
Nisoldipine and nifedipine are two dihydropyridine
compounds that block calcium channel current and are
known to deteriorate when exposed to light (Miles Labora-
tories, product information; Ebel, et al., 1978). The pur-
pose of these experiments is to determine whether the light
sensitivity of these compounds might render them useful as
reversible organic calcium channel blockers. Our results
indicate that inhibition of calcium channel current by
nisoldipine and nifedipine, but not by some other dihydro-
pyridine derivatives that we studied, can indeed be effec-
tively and rapidly reversed by illumination. Some of these
results have been briefly reported to the Biophysical Soci-
ety (Kass and Sanguinetti, 1983).
METHODS
Hearts were obtained from calves at a local slaughterhouse and trans-
ported to the laboratory in cold (40C) Tyrode's solution continuously
gassed with 100% 02. Transport time from removal of the heart from the
animal to arrival in the laboratory averaged 15 min. Shortened (0.5-1.5
mm) Purkinje fibers (100-200 gm diam) were excised from either
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ventricle and placed in warm (35°C) oxygenated Tyrode's solution until
used.
Membrane current was measured using a conventional two microelec-
trode voltage clamp technique (Siegelbaum and Tsien, 1980). Current
signals were filtered at I kHz, digitized, and recorded on a PDP-1 123
computer (Digital Equipment Corp., Marlboro, MA). Electrodes were
pulled from thin walled omega-dot glass (Glass Company of America,
Bargaintown, NJ) and then beveled using a modified spin-bar beveler
(Corson et al., 1979).
All action potential experiments were carried out at a 0.2-Hz drive
rate. Action potentials were stimulated steadily at this rate before, during,
and after application of drug (in the dark). Stimulation was continued at
this rate while the light beam was turned on. In all voltage clamp
experiments, calcium channel current was measured by applying depolar-
izing voltage pulses from a fixed holding potential at a fixed pulse
frequency (0.2-0.25 Hz). In any given experiment, pulse rate was
constant and steady before, during, and after applying a drug in the dark.
The same rate was maintained while the light beam was turned on. Thus,
in any given experiment, the interpulse interval was always the same
during control conditions and after exposure to drug (±light). Current-
voltage curves were determined by measuring membrane current after
the capacity transient had settled following the imposed change in
membrane potential.
Light Source
The light source was a 100-W tungsten bulb (Klinger Scientific Corp.,
Richmond Hill, NY). The lamp was powered by a 12 V DC storage
battery. Light from the lamp was passed through an infrared rejection
filter (Eastman Kodak Co., Rochester, NY) to eliminate possible temper-
ature-dependent effects. The light beam was then collimated via a two slit
Kohler arrangement, and appropriate wavelengths were chosen by pass-
ing the beam through long pass cut-on filters (Oriel Corp., Stamford,
CT). The filtered beam was then focused onto a preparation with a long
working distance 20X (0.33 numerical aperture) microscope objective
(Nikon Inc., Instrument Div., Garden City, NY). The size of the focused
beam could be selected by adjusting one of the collimating slits (see Kass,
1981 for optical arrangement).
Tests for local temperature changes were carried out by placing a small
thermistor (#UUT51J1, Fenwall Electronics, Farmingham, MA) in the
chamber directly in line with the light source. These tests confirmed that
the infrared rejection filter prevented local heating of the Tyrode's
solution (and thus the fiber) by the light source. With this filter in place
local temperature was controlled to within ±0.50C.
Absorption Spectrophotometry
Absorption spectra for solutions of the dihydropyridine compounds were
measured over a limited region of ultraviolet and visible light with a
spectrophotometer (model 25; Beckman Instruments, Inc., Fullerton,
CA). The drugs were dissolved in optical grade methanol and the
absorption spectrum was determined for each drug before and after
illumination with the tungsten-halogen lamp.
Solutions and Drugs
The standard modified Tyrode's solution contained 150mM NaCl, 4 mM
KCI, 5.4 mM CaC12, 0.5 mM MgCl2, 5 mM glucose, and 10 mM Tris
(pH 7.4). In voltage clamp experiments, iontophoretic injection of
tetrabutylammonium (TBA) was performed to reduce the transient
outward current (4,0) and the delayed rectifier, Ix (Kass et al., 1982). INa
was inhibited by tetrodotoxin (TTX, 10 AM) or inactivated by choice of
holding potential. In some experiments CaC12 was replaced with 5.4 mM
SrCl2 to enhance calcium channel current. All solutions were gassed with
100% 02-
Temperature was regulated with a thermoelectric device (Cambion,
Cambridge, MA) over a range of 34-370C, but held constant during a
given experiment to within ±0.50C. Nisoldipine, nitrendipine, and nifedi-
pine were dissolved in polyethylene glycol 400 in stock concentrations of
10 mM. Aliquots of these stock solutions were added directly to the
Tyrode's solution to achieve final desired concentrations. Nicardipine and
D600 stock solutions were prepared using distilled water as a solvent.
Experiments were performed under light filtered through a safelight filter
00 (Eastman Kodak Co.).
Nisoldipine and nitrendipine were kindly supplied by Miles Laborato-
ries (West Haven, CT). Nicardipine was a gift from Syntex (Palo Alto,
CA), and D600 was kindly provided by Knoll Pharmaceutical (Ludwig-
shafen and Rhein, Federal Republic of Germany). TBA chloride was
purchased from Sigma Chemical Corp. (St. Louis, MO), and TTX was
obtained from Calbiochem-Behring Corp., (American Hoechst Corp.,
San Diego, CA). Data are expressed as means ±SEM (n equals the
number of experiments).
RESULTS
Action Potential Studies: Light Can
Modulate Calcium Antagonist Suppression
of the Plateau
At micromolar concentrations, nisoldipine (applied under
subdued illumination) (Kass, 1982) and other calcium
antagonists (Kass and Tsien, 1975) dramatically lower and
shorten the plateau phase of the Purkinje fiber action
potential. The effects caused by exposure to nisoldipine (10
,tM) can be effectively reversed by focusing a beam of light
on the preparation for -5 min (Fig. 1 A). This effect is
observed even if drug superfusion is uninterrupted during
illumination. When the light beam is turned off and the
fiber continues to be superfused with drug, the effects of
nisoldipine redevelop in -7 min (not shown). These
changes appear to be due to an interaction of light with the
drug molecule as exposure to light alone had no effect on
the action potential in five preparations. These results are
consistent with known properties of nisoldipine as it is
known to deteriorate in sunlight (half-life under 10 min,
Miles Laboratory product information). Similar results
were obtained when fibers were treated with nifedipine and
subsequently illuminated.
In contrast, other dihydropyridine calcium antagonists,
nitrendipine and nicardipine, are not as sensitive to sun-
light. For example, in sunlight nitrendipine has a half-life
of 5-35 h (Miles Laboratories product information). Simi-
larly, exposure of a 0.5% solution of nicardipine in water to
sunlight for 24 h results in only 2% degradation (Dr. L.
Sanders, personal communication). Thus, as expected,
illumination of fibers treated with nitrendipine (Fig. 1 B)
or nicardipine (not shown) did not reverse the effects of
these drugs on the Purkinje fiber action potential plateau.
The influence of light on the interaction of these drugs
with the action potential suggested that illumination might
modulate calcium channel blockade by nisoldipine and
nifedipine, but not by the other dihydropyridine com-
pounds. Voltage clamp experiments were carried out to test
this possibility more directly.
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Voltage Clamp Studies: Influence of Light
on Calcium Channel Block
Nisoldipine. Fig. 2 shows the effects of nisoldi-
pine on calcium channel current before and after an 8-min
exposure to the light beam. Voltage steps were applied to a
series of test potentials from a holding potential of -50
mV, and currents were measured after the capacity tran-
sient had settled. In the absence of drug, calcium channel
current contributes inward current at voltages more posi-
tive than -40 mV, and this inward current is completely
blocked after a 15-min exposure to 500 nM nisoldipine.
This block was effectively reversed by subsequent exposure
to the light beam as the figure indicates. In this experi-
ment, -83% of the current blocked by nisoldipine was
recovered by illumination. This result is typical of 12 other
experiments, but the percent of drug-blocked current
recovered by light was variable and relatively insensitive to
drug concentration. The results of these experiments,
CONTROL DRUG DRUG + LIGHT
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FIGURE 1 Effect of illumination on the Purkinje fiber action potential
in the absence and presence of dihydropyridine calcium antagonists. (A)
The left-hand records show superimposed action potentials recorded
before and after a 10-min exposure to the light beam when no drug was
present. Then the chamber was superfused with 10 MM nisoldipine. After
12 min, the drug had markedly lowered and shortened the plateau phase
of the action potential (right traces). Illumination of the preparation for
10 min restored the action potential towards its original configuration
(lower traces). Preparation 276-2. (B) A similar sequence was carried
out with 10 ,uM nitrendipine. In this case, records are shown after a
20-min exposure to the drug (right panel), and subsequent illumination
had no effect on the action potential (lower traces). Preparation 282-4.
-100
FIGURE 2 Light modulates inhibition of calcium channel current by
nisoldipine. Inset: Membrane current recorded in response to voltage
steps to -1 mV from a -42 mV holding potential in the absence of drug
(-), after an 18-min exposure to 500 nM nisoldipine (o) and then in the
presence of this drug concentration but after illuminating the preparation
for 8 min (-). Current-voltage curves were determined in each case as
described in Methods. The curves in the figure are hand-drawn. 5.4 mM
Sr2+-Tyrode's solution. Preparation 300-3.
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summarized in Table I, confirm the action potential stud-
ies.
These experiments were designed to test for changes in
drug-induced blockade of the calcium channel brought on
by exposure to light. Thus, as a control it was necessary to
determine whether light affects calcium channel current in
the absence of drug. To test for this possibility, we
measured peak inward current in response to voltage steps
to potentials near 0 mV from -50 to -45 mV holding
potentials before and after a 5-min exposure to the light
beam. No change in current was seen under these condi-
tions in 13 of 20 fibers studied. But in the remaining seven
fibers we did observe an increase (31 ± 7%) in inward
current.
Fig. 3 shows the effects of nisoldipine on calcium
channel current before and after illumination in a fiber
showing photosensitivity in the absence of drug. A shows
that in this experiment, exposure to light in the absence of
drug resulted in a 19% increase in peak inward drug-
sensitive current. B shows that after complete block of
calcium channel current by 500 nM nisoldipine in the dark,
80% of the control current is recovered by illumination.
Thus, as was the case in our action potential studies, the
light-induced recovery of blocked current appears to be
due primarily to an interaction of light with the drug
molecule.
The voltage dependence of the light-recovered peak
inward current (Fig. 2, *) is similar to that of the drug-free
current (Fig. 2, *). Because this voltage dependence is
largely due to the relationship between the steady state
activation of this channel and voltage (Reuter, 1979), this
result suggests that the voltage-dependence of calcium
channel activation is not altered after drug block is
reversed by light.
We next tested for possible changes in inactivation of
light-recovered calcium channel current under these condi-
tions. Such tests are important as it has been reported that
some dihydropyridines alter the kinetics of calcium chan-
nel inactivation in cardiac cells (Lee and Tsien, 1983). A
simple test for a change in the kinetics of calcium current
inactivation is shown in Fig. 4. A shows current measured
in response to a voltage step to + 18 mV recorded in (a)
TABLE I
BLOCK OF CALCIUM CHANNEL CURRENT BY
NISOLDIPINE AND PERCENT RECOVERED BY
ILLUMINATION
Percent of Percent of
current blocked blocked current
[Nisoldipinel by nisoldipine recovered by light Range n
10JM 100% 65 ± 10% 20-100% 8
500 nM 100% 64 ± 5% 50-72% 4
200nM 63 ± 8% 73 ± 10% 50-100% 4
100nM 50% 80,100 2
Holding potential was between -42 and -55 mV.
mY AB
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FIGURE 3 Photoalteration of membrane current in the absence and
presence of nisoldipine (500 nM). Membrane current was measured in
response to a 200-ms voltage step from a - 42 mV holding potential. (A)
In the absence of drug current was recorded before (6) and after (o) a
7-min exposure to the light beam. (B) The preparation was then exposed
to nisoldipine (500 nM) under subdued illumination. After 12 min in this
solution, calcium channel current was completely blocked (U). The light
beam was then turned on, and light-recovered current was recorded after
a 7-min illumination period (E). 5.4 mM Sr2+-Tyrode's solution. Prepa-
ration 300-2.
control solution and (b) in the presence of nisoldipine in the
dark. The current was partially recovered by exposing the
fiber to the light beam for 6 min (c). In B, the total
drug-sensitive current was obtained by taking the differ-
ence between traces a and b. In addition, the light-
recovered current was determined by subtracting b from c.
The latter difference current was then multiplied by a
factor of 2.5 and displayed in the figure. The scaled
light-recovered current superimposes with total drug-sensi-
tive current for the duration of the test pulse indicating
that the kinetics of inactivation remained unchanged.
. e4,f, 1200 nA
4 'i ,eS
* 2.SI"
FIGURE 4 Inactivation kinetics of light-recovered current remains
unchanged. The left panel shows membrane current recorded (a) before
and (b) after exposure to nisoldipine (500 nM) in the dark. The
preparation was then exposed to the light beam for 6 min and c was
recorded. Total current blocked by the drug in the dark was obtained from
the difference between a and b (a-b, right panel). The current recovered
from drug block by light exposure was obtained from the difference
between b and c, (c-b). This latter difference was then multiplied by a
scale factor of 2.5 and also displayed on the right. The scaled light-
recovered current superimposes with the drug-blocked current for the
duration of this test pulse. 5.4 mM Sr2+-Tyrode's solution. Preparation
301-1.
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Compounds Not Affected by Light
Our results with action potentials suggested that several
compounds that block calcium channel current might not
be affected by light. Calcium channel block by nitrendi-
pine (Fig. 5 A) and D600 (Fig. 5 B) was not reversed by
prolonged illumination.
Wavelength Dependence of the Effect of
Light on Nisoldipine
Ebel et al. (1978) determined by several analytical tech-
niques that nifedipine was converted to a nitroso pyridine
derivative when illuminated for 10 min with a 300-W light
source. The peak of the absorption spectrum of this
pyridine derivative was shifted to shorter wavelengths
compared with nifedipine. For comparison, we determined
the absorption spectrum of nisoldipine (in methanol) over a
similar range of the ultraviolet and visible electromagnetic
spectrum before and after illumination with our light
source. As shown previously for nifedipine by Ebel et al.
(1978) the peak of the absorption spectrum of nisoldipine
was also shifted to shorter wavelengths after exposure to
light (Fig. 6 A, B). The light-induced change in the absorp-
tion spectrum suggested that light of wavelengths shorter
than 450 nm would be the effective energy range that
converts nisoldipine to its inactive form as a calcium
channel blocker.
The absorption spectrum of a nitrendipine solution was
not altered by illumination (not shown). The absence of
A
01 I~~~~~~~~~
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FIGURE 5 Calcium channel current blockade by nitrendipine or by
D600 is not altered by light. (A) The figure shows membrane current in
response to a voltage step to + 2 mV from a -55 mV holding potential in
the absence and presence of 500 nM and 10 AM nitrendipine. During
exposure to each drug concentration, the fiber was illuminated for 10 mm
and traces that were then obtained are also shown. Nitrendipine
continued to further block inward current even in the presence of light,
and the resulting traces are subsequently more outward in each case. 5.4
mM Sr2+-Tyrode's solution. Preparation 313-1. (B) A similar protocol
was followed using 10lgM D600. The figure shows membrane current in
response to a voltage step to -3 mV from a -52 mV holding potential in
the absence and presence of D600, and in the presence of D600 after a
10-mm exposure to the light beam. The D600 traces superimpose before
and after illumination. 5.4 mM Ca2-Tyrode's solution. Preparation
280-4.
photoalteration is consistent with the inability of light to
reverse calcium channel block by nitrendipine.
We then determined the energy dependence of the
light-induced reversal of nisoldipine's block of calcium
channel current. Light of a specified range was selected by
placing a wide band long-pass filter between the light
source and the focusing lens. These filters transmit wave-
lengths longer than a characteristic "cut-on" frequency
and block light of lower wavelengths. The results showed
that light at wavelengths 2 450 nm was not effective in
converting nisoldipine to its less active form. It is not likely
that light at wavelengths shorter than 325 nm contributes
significantly to the modulation of nisoldipine's inhibition of
calcium channel current in our experiments since the
power output of our quartz halogen lamp falls off very
steeply between 450 nm and 300 nm (Oriel Corp., product
infoormation) and, in addition, light in this energy is
further attenuated by glass and plastic components of the
optical system.
Relative Blocking Potency of Nisoldipine
That is Exposed to Light
Illumination of the fiber after exposure to nisoldipine
usually only resulted in partial recovery of the current
previously blocked by the drug (Table I). The question
remained, therefore, whether the light source used was
ineffective in altering enough of the nisoldipine in the
chamber to render its blocking effect negligible within the
fiber, or whether the light-exposed compound simply has a
less potent calcium channel blocking activity. To test the
hypothesis that the light-induced derivative of nisoldipine
has some intrinsic Ca2+-channel blocking action, a stock
solution of nisoldipine (10 mM) was dissolved in methanol
and illuminated for 1 h with unfiltered light from the
tungsten-halogen lamp. The yellow stock solution became
transparent after light exposure and the same change in
the absorption spectrum (as shown in Fig. 6) was pro-
duced. The stock solution was then diluted 1:1,000 in
Tyrode's solution and superfused through the tissue cham-
ber. The nisoldipine that had been exposed to light
decreased peak inward current by 15% after 15 min. The
same fiber was then exposed to 10 ,uM nisoldipine that had
not been exposed to light and complete block of inward
current occurred in 17 min (Fig. 7). In another experiment
nisoldipine, similarly pre-exposed to light, blocked 13% of
the drug sensitive inward current in 20 min. In 13 other
experiments, 10 ,uM nisoldipine that had not been exposed
to light blocked 30% of drug sensitive current in 5.9 ± 0.6
min, and resulted in complete block in 16.7 ± 1.1 min.
Thus, it appears that the light-exposed drug molecule does
have some activity as a calcium channel blocker, but much
less than the activity of the drug that has not been exposed
to light (wavelengths < 450 nm). This blocking activity of
the light-treated compound could account for some of the
current that was not recoverable (35 ± 10%, n = 8) by
illumination after exposure to 10 ,uM nisoldipine.
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FIGURE 6 Ultraviolet and visible absorption spectra of 5 x 10-5 M
nisoldipine (A) before and (B) after lumination of solution with tungsten-
halogen lamp. There was no absorption at wavelengths > 500 nm.
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FIGURE 7 Effect of light-exposed nisoldipine on calcium channel cur-
rent. Membrane current is shown in response to a voltage step to -1 mV
from a -48 mV holding potential in the absence of drug (0) and 10 and
15 min after exposing the fiber to nisoldipine that had previously been
exposed to the halogen light beam as described in the text. The upper
trace (drug in dark), was then recorded 12 min after addition of
nisoldipine (10 ;tM) that had been stored in the dark. All records were
obtained under subdued laboratory illumination as described in Methods.
5.4 Sr2"-Tyrode's solution. Preparation 310-1.
Reversible Organic Calcium Channel
Blockers
The results of this study indicate that calcium channel
blockade by some, but not all, dihydropyridine derivatives,
can be substantially modulated by illumination. The dihy-
dropyridines with an o-nitrophenyl linked to the pyridine
ring (nisoldipine and nifedipine) are very sensitive to light.
In contrast, the dihydropyridine compounds with a m-
nitrophenyl substituent (nitrendipine) are far less sensitive
to light. Thus it seems that the o-nitrophenyl substituted
dihydropyridines will be useful in studies where reversible
block of the calcium channel is desired. In addition these
compounds will be very useful as probes for localized
calcium-dependent processes, since local illumination can
be used to selectively reveal areas that contain calcium
channels. Our observations in mammalian cardiac Pur-
kinje fibers are similar to recent findings by Morad et al.
(1983) in frog heart.
Relative Potency of Light-exposed
Nisoldipine
Exposure to light was not always 100% effective in revers-
ing calcium channel inhibition by high nisoldipine concen-
trations. Some of this variability may be attributed to the
considerable variation in fiber size and in the amount of
collagen that surrounds the core of cells in a calf Purkinje
fiber preparation. If nisoldipine acts at the inner surface of
the cell membrane, then the intensity of light that reaches
intracellular nisoldipine determines the effectiveness of
illumination in recovering blocked current. An increase in
either fiber size or the amount of connective tissue could
reduce the intensity of this light and thus the efficiency of
current recovery.
On the other hand, our results show that light-exposed
drugs do have some intrinsic calcium channel blocking
properties. Our results cannot discriminate between the
possibility that the light-altered drug binds to the same
membrane receptor as nisoldipine but with less affinity,
and/or that it binds with a similar affinity but blocks the
calcium channel less effectively. However, the block of
calcium channel current by nisoldipine can be reversed by
washout only if the fiber is simultaneously illuminated.
This suggests that the light-altered drug binds with less
affinity. Light-treated nisoldipine is a weak calcium chan-
nel current inhibitor but this should not limit the usefulness
of light as a modulator of this blocker, especially if low
drug concentrations (<200 nM) are used.
Comparison with Previous
Structure-Activity Studies
Ebel et al. (1978) reported that nifedipine is converted to a
nitroso-containing pyridine derivative when exposed to
intense light. It has not been reported if conversion of the
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o-nitro moiety to a nitroso derivative has any effect on
potency of dihydropyridines. However, Rodenkirchen et al.
(1978) have shown that the o-nitro substituent is nonessen-
tial for the characteristic action of nifedipine. The negative
inotropic effect of the pyridine analogue of nifedipine is
more than two orders of magnitude less potent than
nifedipine (Mannhold et al., 1982). The pyridine analog of
nifedipine is -25% effective as a negative inotropic agent
at a concentration that fully inhibits contraction of isolated
papillary muscles exposed to an equimolar concentration
(10 ,uM) of nifedipine (Rodenkirchen et al., 1982; Mann-
hold et al., 1982).
We find that the relative potency of nisoldipine and the
drug produced by exposing nisoldipine to light is similar to
that shown for nifedipine and its pyridine derivative
(Mannhold et al., 1982). Furthermore, the absorption
spectra for the nisoldipine solution before and after expo-
sure to the light source are similar to comparable spectra
for nifedipine (Ebel et al., 1978). Thus, from our experi-
ments it seems likely that nisoldipine is also converted to a
pyridine derivative in light (also see Morad et al., 1983),
and this derivative is -20% as effective as nisoldipine in
inhibiting calcium channel current.
Effects of Light in the Absence of Drug
We occasionally observed light-induced changes in the
action potential or membrane current in the absence of
drug. This effect was always in the direction of a light-
induced increase in calcium channel current. This action
could not have been caused by the presence of residual
drug in the tissue chamber since considerable effort was
made to clean the chamber between each experiment.
It is not clear why these changes occur, but the action
spectrum for this effect is similar to that for the effect of
light on drug-induced calcium channel blockade. Thus,
light in the near ultraviolet region of the spectrum is
responsible for this effect. UV light has been reported to
alter sodium channel conductance in nerve (Oxford and
Pooler, 1975; Fox and Stampfli, 1971) and contractile
activity in cardiac muscle (Morad et al., 1983). But, as in
the case of our experiments, the mechanism responsible for
these changes is not clear.
In summary, we find that calcium channel blockade by
the dihydropyridine compounds nifedipine and nisoldipine
can be reversed by exposure to light. This procedure
provides reversible organic calcium channel blockers that
should prove to be valuable probes of the roles of calcium
channels in many aspects of cellular function.
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